1074746

ACS Dobfar s.p.a. — FEI 3009807048

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 8, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Agrate Brianza (Italy)

Additional Details

Postmarket Adverse Drug Experience (PADE)